Faculty profile
Sean Egan
Back to facultyResearch
Read how they describe their research on their University of Toronto profile.
Latest papers
A forward genetic screen identifies potassium channel essentiality in SHH medulloblastoma maintenance.
Developmental cell · 2025
Latest funding
- $65,000
Plakoglobin, a regulator of pluripotency and Wnt/beta-Catenin-mediated transformation
CIHR · 2024 · Nominated PI
- $979,200
16q hemizygous loss in breast cancer: The central driver for tumor initiation, invasion and progression
CIHR · 2021 · Nominated PI
- $956,250
Targeting the immune landscape at presentation and relapse of Immune-Related Lobular Breast Cancer
CIHR · 2019 · Nominated PI
1 publications.
A forward genetic screen identifies potassium channel essentiality in SHH medulloblastoma maintenance.
Fan JJ, Erickson AW, Carrillo-Garcia J, Wang X, Skowron P, Wang X, Chen X, Shan G, Dou W, Bahrampour S, Xiong Y, Dong W, Abeysundara N, Francisco MA, Pusong RJ, Wang W, Li M, Ying E, Suárez RA, Farooq H, Holgado BL, Wu X, Daniels C, Dupuy AJ, Cadiñanos J, Bradley A, Bagchi A, Moriarity BS, Largaespada DA, Morrissy AS, Ramaswamy V, Mack SC, Garzia L, Dirks PB, Li X, Wanggou S, Egan S, Sun Y, Taylor MD, Huang X
Plakoglobin, a regulator of pluripotency and Wnt/beta-Catenin-mediated transformation
Principal investigators: Egan, Sean E
Keywords: Breast Cancer
16q hemizygous loss in breast cancer: The central driver for tumor initiation, invasion and progression
Principal investigators: Egan, Sean E
Keywords: Breast Cancer; Genetics; Mouse Modeling; Theraepeutics; Tumor Suppressors
Targeting the immune landscape at presentation and relapse of Immune-Related Lobular Breast Cancer
Principal investigators: Egan, Sean E
Keywords: Breast Cancer; Combination Therapy; Estrogen Receptor; Immune Checkpoint Therapy; Immunotherapy; Lobular Breast Cancer; Metastasis; Mouse Modeling; Progression; Recurrence
Notch as master regulator of breast cancer subtype and intratumoral heterogeneity
Principal investigators: Egan, Sean E; Ben-Porath, Ittai
Keywords: Asymmetry; Breast Cancer; Cell Fate; Heterogeneity; Human Culture Systems; Mouse Models; Notch; P53; Polycomb Complexes
Chromosome 16q, a Cancer Suppressor Chromosome Arm
Principal investigators: Egan, Sean E
Keywords: Breast Cancer; Cbfb; Cdh1; Chromosome 16q; Chromosome Engineering; Ctcf; E-Cadherin; Lobular Breast Cancer; Pik3ca; Tumor Suppressor
Defining the function of Gata3 and TRPS1, A GATA-like protein, in BC
Principal investigators: Egan, Sean E
Keywords: Breast Cancer; Gata3; Mouse Genetics; Pi3k; Rad21; Transposons; Trps1
Addressing tumor heterogeneity through identification of subgroup-specific "shared maintenance genes" - the right target for each cancer
Principal investigators: Egan, Sean E; Taylor, Michael D; Woodgett, James (Jim) R; Zacksenhaus, Eldad
Keywords: Breast Cancer; Medulloblastoma; Metastasis; Oncogene Addiction; P53; Pi3k; Rb; Shared Maintenance Genes; Shh; Wnt
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Department of Molecular Genetics
- Developmental Stem Cell Biology
- Toronto General Research Institute
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Yu Sun
Toronto General Research Institute
1 shared papers, latest 2025
Xi Huang
Faculty
1 shared papers, latest 2025
Vijay Ramaswamy
Developmental Stem Cell Biology
1 shared papers, latest 2025
Livia Garzia
Faculty
1 shared papers, latest 2025
Wei Wang
Faculty
1 shared papers, latest 2025
Livia Garzia
Faculty
1 shared papers, latest 2025
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.